Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Societe Francaise des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study - Rubie, H; Chisholm, J; Defachelles, A S (J Clin Oncol, 2006)
et al.